NCT06644144 - P4O2 ILD Extension | Biotech Hunter

Enrollment

450

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

October 1, 2028

Study Completion Date

October 1, 2031

Conditions

Interstitial Lung DiseasePulmonary FibrosisInterstitial Lung FibrosisIPFPulmonary Fibrosis, IdiopathicPulmonary Fibrosis Idiopathic FamilialChronic Hypersensitivity PneumonitisUnclassifiable ILDIdiopathic NSIPCTD-ILD

Interventions

OTHER

No Interventions

No intervention so not applicable.

Trial Locations (1)

1081 HV

RECRUITING

Amsterdam UMC, locatie VUmc, Amsterdam